Sorrento Therapeutics, Inc. - 16 Jul 2021 Form 3 Insider Report for Celularity Inc (CELU)

Role: 10%+ Owner
Signature: By: /s/ Henry Ji, Ph.D., President, Chief Executive Officer and Chairman of the Board, Sorrento Therapeutics, Inc.
Issuer symbol: CELU
Transactions as of: 16 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 23 Jul 2021, 06:04:35 UTC
Next filing: 15 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CELU	Class A Common Stock						20,422,124	16 Jul 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.